News

Back General News Investor Updates

Emyria Expands MDMA Analogue Library to Address Mental Health and Neurological Disorders

Emyria Expands MDMA Analogue Library to Address Mental Health and Neurological Disorders

Our MDMA-analogue library has grown to over 150! An additional 19 compounds have been sent for safety screening.

These ‘next-generation’ MDMA-inspired compounds are aimed at treating conditions like Post-Traumatic Stress Disorder, Parkinson’s Disease and fibrotic disease – with some already in pre-clinical testing.

Read more: Emyria Grows MDMA Asset for Neuro & Mental Health Therapy | Emyria Investor Hub

Call 08 6559 2800Contact